EPL Ltd Q4 FY2025 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/z21dqsfwusqqwyu91nrgngv6.pdf

Key Takeaways


The Beauty & Cosmetics Pivot

Kripalu: "On Beauty & Cosmetics, the mantra in the company is we will do what it takes to accelerate Beauty & Cosmetics. No size of order is too small for EPL to go and service that order."

Margin Trajectory & Levers

Kripalu: "As a principal I can tell you we are the lowest cost producer in the world right by at least 3%, if not more. And that is because compared to any other regional competitor, the Indian mindset of frugality as a culture, right, and our ability to extract more from the machines and run our machines for longer than anybody else in the world."

Geographic Performance & Expansion

RegionTrendCommentary
Americas▲ Solid growthRevenue growth driver alongside EAP; margins at 18-19% with room to improve. Local US manufacturing insulates against tariffs.
EAP▲ Strong growthGrew 9% YoY in Q4 despite Chinese New Year headwinds; will get a further boost in H2 as Thailand comes on stream. EAP must perform for the global double-digit ambition.
Europe▬ Modest growthMargins at 16-17% are in the right range with some opportunity left; the Poland plant turnaround has helped the regional profit mix.
AMESA (India)▬ Flat overallUnderlying tube demand remains positive; flatness was partly due to lower intercompany laminate sales, a quarterly inventory variation, not structural. Tube revenue growth ex-laminates is mid-to-high single digit.

Tariffs & Competitive Dynamics

Kripalu: "Actually, there could be a source of competitive advantage, right as this thing plays out."

Capital Allocation & Returns


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthDouble-digit growth globallyFY26
EBITDA growthEBITDA growth ahead of revenue growthFY26
Beauty & Cosmetics growthMid-to-high teens growth globallyFY26
Brazil capacityNew B&C capacity operationalQ1 FY26 (this quarter)
Thailand greenfieldBegin contributing to revenueH2 FY26
CAPEX₹380-₹390 crore spendFY26
ROCECross 20%Short term
DividendContinue strong payout with marginal YoY improvementOngoing

Key Metrics

MetricQ4 FY25
Revenue growth7.4% YoY
EBITDA growth17.7% YoY
PAT growth42.4% YoY
EBITDA margin20.3%, 11th consecutive quarter of expansion
Full-year revenue growth7.6% YoY
Full-year EBITDA growth17.5% YoY, margin expansion of 169 bps
Full-year underlying PAT growth44.6% YoY
EPS₹11.38 in FY25, up 44% from ₹7.88 in FY24
ROCE18%, expanded by 335 bps
Net debt to EBITDA0.54x
Personal Care & Beyond revenue share48% of total business
Personal Care & Beyond growth10.3% YoY (full year)
Oral Care growth5.6% YoY (full year)
Beauty & Cosmetics growthOver 20% YoY
India margin improvement100 bps YoY, 170 bps sequential
EAP region growth9% YoY
Europe EBITDA margin16%–17%
Americas EBITDA margin18%–19%
Recyclable portfolio share33%, up from 21% last year
Brazil capacity addition~4 crore tubes per year
FY26 CAPEX guidance₹380–₹390 crore
FY25 dividend per share₹5.00 (proposed final of ₹2.50 included), vs ₹4.35 last year
Steady-state tax rate guidance18%–22%